TY - JOUR
T1 - The EHA research roadmap
T2 - Platelet disorders
AU - Balduini, Carlo
AU - Freson, Kathleen
AU - Greinacher, Andreas
AU - Gresele, Paolo
AU - Kühne, Thomas
AU - Scully, Marie
AU - Bakchoul, Tamam
AU - Coppo, Paul
AU - Drnovsek, Tadeja Dovc
AU - Godeau, Bertrand
AU - Gruel, Yves
AU - Rao, A. Koneti
AU - Kremer Hovinga, Johanna A.
AU - Makris, Michael
AU - Matzdorff, Axel
AU - Mumford, Andrew
AU - Pecci, Alessandro
AU - Raslova, Hana
AU - Rivera, José
AU - Roberts, Irene
AU - Scharf, Rüdiger E.
AU - Semple, John W.
AU - Van Geet, Christel
PY - 2021/7/1
Y1 - 2021/7/1
N2 - In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy.
AB - In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy.
U2 - 10.1097/HS9.0000000000000601
DO - 10.1097/HS9.0000000000000601
M3 - Review article
C2 - 34476343
AN - SCOPUS:85109481532
SN - 2572-9241
VL - 5
JO - HemaSphere
JF - HemaSphere
IS - 7
M1 - e601
ER -